Search Count: 26
 |
Crystal Structure Of Human Kras G12C Covalently Bound To Divarasib (Gdc6036)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-05-21 Classification: ONCOPROTEIN,HYDROLASE/INHIBITOR Ligands: A1AWR, MG, GDP |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-05-21
Ligands: A1AWR, MG, GDP
 |
Hsp90 Ntd In Complex With Compound 6
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-10-16 Classification: CHAPERONE Ligands: A1AG2, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-10-16
Ligands: A1AG2, MG
 |
Structure Of Akt1(E17K) With Compound 3
Organism: Homo sapiens, Lama glama
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2024-09-04 Classification: TRANSFERASE/INHIBITOR Ligands: EDO, XOO, SO4, ZN |
Organism: Homo sapiens, Lama glama
Method: X-RAY DIFFRACTION
Release Date: 2024-09-04
Ligands: EDO, XOO, SO4, ZN
 |
Structure Of Akt1(E17K) With Compound 3 (Zinc-Free)
Organism: Homo sapiens, Lama glama
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2024-09-04 Classification: TRANSFERASE/INHIBITOR Ligands: EDO, XOO, SO4 |
Organism: Homo sapiens, Lama glama
Method: X-RAY DIFFRACTION
Release Date: 2024-09-04
Ligands: EDO, XOO, SO4
 |
Structure Of Akt1(Wt) With Compound 3
Organism: Homo sapiens, Lama glama
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2024-09-04 Classification: TRANSFERASE/INHIBITOR Ligands: EDO, XOO, SO4 |
Organism: Homo sapiens, Lama glama
Method: X-RAY DIFFRACTION
Release Date: 2024-09-04
Ligands: EDO, XOO, SO4
 |
Structure Of Akt1(E17K) With Compound 4
Organism: Homo sapiens, Lama glama
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2024-09-04 Classification: TRANSFERASE/INHIBITOR Ligands: XQ2, EDO, SO4, ZN, CL |
Organism: Homo sapiens, Lama glama
Method: X-RAY DIFFRACTION
Release Date: 2024-09-04
Ligands: XQ2, EDO, SO4, ZN, CL
 |
Structure Of Akt2 With Compound 3
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-09-04 Classification: TRANSFERASE/INHIBITOR Ligands: XOO, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-09-04
Ligands: XOO, EDO
 |
Wdr5 Covalently Modified At Y228 By (R)-2-Sf
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2023-05-31 Classification: GENE REGULATION/INHIBITOR Ligands: XKN, GOL, SO4, CL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-05-31
Ligands: XKN, GOL, SO4, CL
 |
Signal Peptide Mimicry Primes Sec61 For Client-Selective Inhibition
Organism: Synthetic construct, Ovis aries
Method: ELECTRON MICROSCOPY Release Date: 2023-03-22 Classification: MEMBRANE PROTEIN |
Organism: Synthetic construct, Ovis aries
Method: ELECTRON MICROSCOPY
Release Date: 2023-03-22
 |
Structure Of The Ev71 3Cpro With 337 Inhibitor
Organism: Enterovirus a71
Method: X-RAY DIFFRACTION Resolution:1.31 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: G7L |
Organism: Enterovirus a71
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: G7L
 |
Structure Of The Sars-Cov-2 Main Protease With 337 Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: G7L |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: G7L
 |
Structure Of The Ev71 3Cpro With 338 Inhibitor
Organism: Enterovirus a71
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: G7F |
Organism: Enterovirus a71
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: G7F
 |
Structure Of The Sars-Cov-2 Main Protease With En102 Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: G7O |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: G7O
 |
Reversible Lysine-Targeted Probes Reveal Residence Time-Based Kinase Selectivity In Vivo
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2022-06-08 Classification: CELL CYCLE Ligands: 5YZ, CL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-06-08
Ligands: 5YZ, CL
 |
Crystal Structure Of The Rab27A Fusion With Slp2A-Rbda1 Effector For Sf4 Pocket Drug Targeting
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2022-04-06 Classification: EXOCYTOSIS Ligands: GNP, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-04-06
Ligands: GNP, MG
 |
Rab27A Fusion With Slp2A-Rbda1 Effector Covalent Adduct With Ca1 In C188
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2022-04-06 Classification: EXOCYTOSIS Ligands: 06D, GNP, MG, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-04-06
Ligands: 06D, GNP, MG, GOL
 |
Rab27A Fusion With Slp2A-Rbda1 Effector Covalent Adduct With Cb1 In C123
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2022-04-06 Classification: EXOCYTOSIS Ligands: GNP, MG, GOL, 05Y |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-04-06
Ligands: GNP, MG, GOL, 05Y
 |
Cdk2(F80C) With Covalent Adduct Tk37 At F80C
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.66 Å Release Date: 2020-07-22 Classification: TRANSFERASE Ligands: OWN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-22
Ligands: OWN
 |
Cdk2(F80C)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2020-07-22 Classification: TRANSFERASE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-22
 |
Cdk2(F80C) With Covalent Adduct Tk22 At F80C
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2020-07-22 Classification: TRANSFERASE Ligands: OY2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-22
Ligands: OY2